Profile data is unavailable for this security.
About the company
Enorama Pharma AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company is mainly focused on the development of medical chewing gum that contains drugs. The Company's product Nicotine gum is a chewing gum contained drugs that help to overcome nicotine addiction. In addition, the medical chewing gum applications include pain management, allergy, cough and cold, among others. The Company distributes its products in Europe through pharmacy chains and grocery stores.
- Revenue in SEK (TTM)3.82m
- Net income in SEK-76.57m
- Incorporated2006
- Employees5.00
- LocationEnorama Pharma ABVastra Varvsgatan 19MALMO 211 77SwedenSWE
- Phone+46 40140620
- Websitehttps://www.enorama.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Double Bond Phrmcutcl Intrntnl AB (publ) | 278.65k | -841.63k | 28.26m | 9.00 | -- | 2.36 | -- | 101.43 | -0.02 | -0.02 | 0.0035 | 0.056 | 0.027 | -- | 2.99 | 30,961.11 | -8.16 | -75.46 | -11.26 | -104.36 | 2,263.63 | -717.21 | -302.04 | -1,144.39 | -- | 0.78 | 0.00 | -- | -20.52 | 35.18 | 58.98 | -- | 114.06 | -- |
| Pila Pharma AB | 1.13m | -16.86m | 50.50m | 0.00 | -- | 3.42 | -- | 44.81 | -0.5036 | -0.5036 | 0.0347 | 0.3513 | 0.1004 | -- | 10.32 | -- | -150.29 | -120.32 | -168.26 | -134.79 | -516.24 | -185.07 | -1,496.36 | -1,375.02 | -- | -36.05 | -- | -- | 45.44 | -- | -50.01 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 12.21m | -38.09m | 53.73m | 20.00 | -- | 1.51 | -- | 4.40 | -13.66 | -13.66 | 4.29 | 10.11 | 0.1436 | -- | 10.26 | 610,350.00 | -44.80 | -58.07 | -73.58 | -72.39 | 71.16 | -20.28 | -311.99 | -673.47 | -- | -- | 0.0366 | -- | 56.00 | -4.37 | -5.68 | -- | -- | -- |
| Enorama Pharma AB | 3.82m | -76.57m | 56.84m | 5.00 | -- | -- | -- | 14.87 | -1.23 | -1.23 | 0.0595 | -0.0623 | 0.1413 | 2.71 | 2.45 | 764,600.00 | -283.01 | -88.96 | -526.84 | -127.92 | -302.88 | 15.72 | -2,002.90 | -488.89 | 0.5223 | -12.77 | -- | -- | 1,061.12 | 15.68 | 1.81 | -- | -- | -- |
| XP Chemistries AB | 311.47k | -7.67m | 57.77m | 2.00 | -- | 1.46 | -- | 185.48 | -0.042 | -0.042 | 0.0017 | 0.126 | 0.0095 | 3.58 | 9.76 | 155,735.00 | -23.42 | -- | -25.03 | -- | -1,850.65 | -- | -2,461.64 | -- | 17.17 | -- | 0.00 | -- | -57.22 | -- | 11.26 | -- | -- | -- |
| Odi Pharma AB (publ) | 8.97m | -4.72m | 74.05m | 1.00 | -- | 253.14 | -- | 8.25 | -0.2851 | -0.2851 | 0.5266 | 0.016 | 1.33 | -- | 5.29 | 8,971,460.00 | -70.09 | -40.68 | -1,151.76 | -60.97 | -29.08 | -- | -52.61 | -95.17 | -- | -8.51 | 0.00 | -- | -85.94 | -- | -944.49 | -- | -- | -- |
| Oncozenge AB | 2.71m | -15.94m | 77.91m | 1.00 | -- | 9.19 | -- | 28.72 | -1.28 | -1.28 | 0.2238 | 0.6703 | 0.1514 | -- | 1.77 | -- | -88.96 | -49.16 | -122.96 | -55.02 | -- | -- | -587.54 | -3,418.24 | -- | -103.87 | 0.4694 | -- | -- | -- | -83.47 | -- | -- | -- |
| StenoCare A/S | 8.10m | -35.09m | 83.65m | 8.00 | -- | 23.62 | -- | 10.33 | -0.8176 | -0.8176 | 0.1569 | 0.0572 | 0.324 | -- | 3.80 | 709,217.50 | -140.37 | -45.69 | -201.07 | -59.64 | -- | -- | -433.19 | -739.04 | 1.32 | -6.51 | 0.526 | -- | -40.60 | -14.70 | -96.30 | -- | -64.95 | -- |
| Arctic Bioscience AS | 41.74m | -41.16m | 84.44m | 22.00 | -- | 0.4539 | -- | 2.02 | -1.67 | -1.67 | 1.69 | 7.27 | 0.156 | 0.9957 | 4.02 | 1,998,510.00 | -15.39 | -15.49 | -18.84 | -17.83 | 28.45 | 28.52 | -98.62 | -125.49 | 0.3389 | -9.68 | 0.2202 | -- | 28.84 | 7.68 | -5.31 | -- | -- | -- |
| Vivesto AB | 0.00 | -35.72m | 89.68m | 4.00 | -- | 0.3263 | -- | -- | -0.0664 | -0.0664 | 0.00 | 0.2483 | 0.00 | -- | -- | 0.00 | -21.35 | -- | -23.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 69.12 | -- | -- | -- |
| IRLAB Therapeutics AB | 57.46m | -110.01m | 145.79m | 31.00 | -- | 4.75 | -- | 2.54 | -1.75 | -1.75 | 0.8494 | 0.3617 | 0.4188 | -- | 11.05 | 1,853,613.00 | -80.18 | -31.73 | -328.93 | -40.78 | -72.94 | -33.99 | -191.45 | -101.39 | -- | -5.62 | 0.4937 | -- | -39.28 | -- | -32.34 | -- | -- | -- |
| Magle Chemoswed Holding AB | 292.44m | -26.60m | 165.20m | 144.00 | -- | 0.3107 | 5.96 | 0.5649 | -1.29 | -1.29 | 14.56 | 25.75 | 0.3085 | -0.0596 | 8.14 | 1,989,374.00 | -2.81 | 2.43 | -3.45 | 3.45 | 102.66 | 88.63 | -9.09 | 4.76 | 0.8205 | -0.1043 | 0.3887 | 0.00 | 38.49 | 13.10 | -1.91 | 74.06 | -21.72 | -- |
| Isofol Medical AB (publ) | 0.00 | -54.17m | 199.59m | 6.00 | -- | -- | -- | -- | -0.246 | -0.246 | 0.00 | -- | -- | -- | -- | 0.00 | -- | -50.03 | -- | -64.52 | -- | -- | -- | -1,377.23 | -- | -- | -- | -- | -- | -- | -24.56 | -- | -- | -- |
Data as of Feb 27 2026. Currency figures normalised to Enorama Pharma AB's reporting currency: Swedish Krona SEK
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Mar 2025 | 13.96k | 0.02% |
Data from 30 Dec 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
